Two new appointments at AAIPharma
This article was originally published in Scrip
AAIPharma (US) has appointed Dr Andreas Dreps senior vice-president of global clinical development services and Dr Ralf Wolter vice-president of clinical operations – Europe. Dr Dreps has more than 15 years' drug development experience, most recently leading the oncology therapeutic area at ICON. He has also worked at Merck KGaA, Rhône-Poulenc Rorer/Aventis and Bristol Myers-Squibb. Dr Wolter previously served as vice-president of clinical development at Apogenix, a German biotech company focused on oncology.